ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RCEL vs BWAY // ENTERPRISE SCALE & MARKET CAP

Avita Medical Inc. (NASDAQ) VS. BrainsWay Ltd. (NASDAQ) • 15-METRIC TALLY: RCEL 2 — BWAY 0
▲ ENTERPRISE SCALE & MARKET CAP LEADER: RCEL
market-cap
$484.0M
market-cap
$455.9M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RCEL VS. BWAY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RCEL BWAY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 82.10% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.23% — — TIE /fcf-yield <GO>
Operating Margin -59.40% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 11.50% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 — — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.1 42.6 +18.50 RCEL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $484.0M $455.9M $28.1M RCEL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RCEL REV BWAY REV RCEL GROSS % BWAY GROSS % RCEL FCF BWAY FCF
FY 2025 $71.6M — 82.1% — -$32.2M —
FY 2024 $64.3M — 85.8% — -$58.1M —
FY 2023 $50.1M — — — -$38.0M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RCEL // BETA —
BWAY // BETA —